Cargando…
Ocular surface disease: a known yet overlooked side effect of topical glaucoma therapy
Ocular surface disease (OSD), a disorder affecting the lacrimal and meibomian glands and the corneal and conjunctival epithelium, is a well-known complication of topical glaucoma therapy. OSD can present as a new or pre-existing condition that virtually any anti-glaucoma formulation can exacerbate....
Autores principales: | Ruiz-Lozano, Raul E., Azar, Nadim S., Mousa, Hazem M., Quiroga-Garza, Manuel E., Komai, Seitaro, Wheelock-Gutierrez, Lorena, Cartes, Cristian, Perez, Victor L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403269/ https://www.ncbi.nlm.nih.gov/pubmed/37547228 http://dx.doi.org/10.3389/ftox.2023.1067942 |
Ejemplares similares
-
Noxious effects of riot control agents on the ocular surface: Pathogenic mechanisms and management
por: Quiroga-Garza, Manuel E., et al.
Publicado: (2023) -
The development and function of the brain barriers – an overlooked consideration for chemical toxicity
por: Bell, Kiersten S., et al.
Publicado: (2022) -
Chemical toxic exposures and chronic ocular pain
por: Graca, Mateusz, et al.
Publicado: (2023) -
Ocular surface complications following biological therapy for cancer
por: Ma, Kevin Sheng-Kai, et al.
Publicado: (2023) -
Visual function and quality of life in patients with Stevens-Johnson syndrome who received acute protocol-based ocular care
por: Shanbhag, Swapna S., et al.
Publicado: (2022)